A professor of geology and soil science from a North Dakota university will be the next dean of the College of Agricultural, Life and Physical Sciences at Southern Illinois University Carbondale.
Bolsters team with addition of established biopharma industry leaders in advance of anticipated regulatory approval and commercialization of once-nightly.
Confirm
Bolsters team with addition of established biopharma industry leaders in advance of anticipated regulatory approval and commercialization of once-nightly FT218 for narcolepsy
DUBLIN, Ireland, June 02, 2021 (GLOBE NEWSWIRE) Avadel Pharmaceuticals plc ( AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today it has appointed Jeff Cruikshank as Vice President, Sales; Denise Strauss as Vice President, Marketing and New Product Strategy; and Angela Woods as Vice President, People and Culture.
These newly-created roles will continue to build the Company’s capabilities to support the potential approval and commercialization of once-nightly FT218. As Vice President, Sales, Mr. Cruikshank will lead the development of Avadel’s go-to-market customer model including the buildout and deployment of the Company’s patient-focused
Notwithstanding the conflicts between them, the ideologists of the Soviet bureaucracy on the one hand and American capitalism on the other shared a common and politically indispensable lie: that the Soviet leaders were dedicated Marxists and that the Soviet Union was, more or less, a socialist society.